₹316.20
+6.20 (+2.00%)
As of 18 Sept 2026, Bafna Pharmaceuticals Ltd share price is ₹316.20. The stock opened at ₹316.20 and had closed at ₹310.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹95.00 and a high of ₹318.00. In terms of performance, Bafna Pharmaceuticals Ltd share price has increased by 173.25% over the past six months and has increased by 125.70% over the last year.
BAFNAPH Stock Price Chart
Bafna Pharmaceuticals Ltd Overview
Market cap₹733 Crs
Volume3,225
Prev. Close₹310.00
Year range₹95.00 - ₹318.00
ISININE878I01022
About BAFNAPH
Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations.
Bafna Pharmaceuticals Ltd Historical Performance
1 Month Return20.53%
6 Month Return200.82%
3 Year Return245.40%
3 Month Return106.53%
1 Year Return161.05%
5 Year Return140.31%
Bafna Pharmaceuticals Ltd Fundamentals
ROCE(TTM)10.63%
P/E Ratio (TTM)94.22
P/B Ratio7.63
Debt to Equity0.39
ROE11.54%
EPS (TTM)3.29
Dividend Yield0.00%
Book Value40.64
Profit Margin5.46%
Operating Margin3.70%
Bafna Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 155.38 | 148.60 | 155.99 | 118.62 | 86.84 |
| EBITDA | 20.70 | 11.77 | 14.64 | 18.99 | 11.50 |
| Net Profit | 11.10 | 4.15 | 7.35 | 11.34 | 5.22 |
| EPS | 4.69 | 1.76 | 3.11 | 4.79 | 2.19 |
Bafna Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 308.30 |
| Resistance 1 (R1) | 310.85 |
| Pivot Point | 309.15 |
BAFNAPH Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Ravichandran Chitra | Chairperson |
| Shanmugam Hemalatha | E D & Wholetime Directorector |
| Vinayak Dinesh Dendukuri | Executive Director / WTD - Quality |
Bafna Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,861.00+0.40% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,283.00+1.36% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,811.50-0.02% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Bafna Pharmaceuticals Ltd today is ₹316.20 on NSE and ₹316.20 on BSE.
- The 52-week high of Bafna Pharmaceuticals Ltd is ₹318.00, while the 52-week low is ₹95.00.
- The current market capitalisation of Bafna Pharmaceuticals Ltd is approximately ₹733 crore.
- The P/E (Price-to-Earnings) ratio of Bafna Pharmaceuticals Ltd is 94.22. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Bafna Pharmaceuticals Ltd is 7.63. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Bafna Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BAFNAPH on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Bafna Pharmaceuticals Ltd has delivered a return of approximately 245.40%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Bafna Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 75.00% promoters, 9.34% FIIs, 0.00% DIIs, and 11.97% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
